Showing results (41-50 of 54) with videos related to
Sort By:
Pageof 6
Urologic Oncology|November 23, 2021
Impact of preoperative systemic immune-inflammation Index on oncologic outcomes in bladder cancer patients treated with radical cystectomyNico C Grossmann, Victor M Schuettfort, Benjamin Pradere, et al.Journal of Personalized Medicine|November 27, 2021
Evaluation of the Predictive Role of Blood-Based Biomarkers in the Context of Suspicious Prostate MRI in Patients Undergoing Prostate BiopsyPawel Rajwa, Nicolai A Huebner, Dadjar I Hostermann, et al.Minerva Urology and Nephrology|June 11, 2021
Impact of the preoperative modified Glasgow Prognostic Score on disease outcome after radical cystectomy for urothelial carcinoma of the bladderVictor M Schuettfort, Kilian Gust, David D'Andrea, et al.BJU International|March 2, 2021
A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinomaVictor M Schuettfort, David D'Andrea, Fahad Quhal, et al.European Urology Focus|May 31, 2021
Accuracy and Clinical Utility of a Tumor Grade- and Stage-based Predictive Model in Localized Upper Tract Urothelial CarcinomaSatoshi Katayama, Keiichiro Mori, Victor M Schuettfort, et al.European Urology Focus|June 15, 2021
Accuracy of Frozen Section Analysis of Urethral and Ureteral Margins During Radical Cystectomy for Bladder Cancer: A Systematic Review and Diagnostic Meta-AnalysisEkaterina Laukhtina, Pawel Rajwa, Keiichiro Mori, et al.Annals of Surgical Oncology|March 29, 2022
Prognostic Role of Preoperative Vascular Cell Adhesion Molecule-1 Plasma Levels in Urothelial Carcinoma of the Bladder Treated With Radical CystectomyKeiichiro Mori, Victor M Schuettfort, Satoshi Katayama, et al.European Urology Focus|August 29, 2021
The Value of Preoperative Plasma VEGF Levels in Urothelial Carcinoma of the Bladder Treated with Radical CystectomyKeiichiro Mori, Victor M Schuettfort, Satoshi Katayama, et al.European Urology Open Science|May 9, 2022
Comparative Outcomes of Primary Versus Recurrent High-risk Non-muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter StudyNico C Grossmann, Pawel Rajwa, Fahad Quhal, et al.Journal of Cancer Research and Clinical Oncology|January 8, 2022
Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancerSatoshi Katayama, Victor M Schuettfort, Benjamin Pradere, et al.Pageof 6